Serotherapy of malignant disease.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000912:Antibodies, Neoplasm / Q000494:pharmacology; D001500:BCG Vaccine / Q000627:therapeutic use; D001667:Binding, Competitive; D002051:Burkitt Lymphoma / Q000188:drug therapy; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology; D007111:Immunity, Cellular / Q000187:drug effects; D007116:Immunization, Passive; D007680:Kidney Neoplasms / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000276:immunology; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology
D000912:Antibodies, Neoplasm; D001500:BCG Vaccine; D007106:Immune Sera